Laden…
Substance Comparison
Benzodiazepine and GBL are both classified as Depressiva. Benzodiazepine is commonly associated with a moderate risk profile compared to GBL.
Both substances belong to the Depressiva class, making this a common comparison for understanding differences within the same pharmacological family.
No significant profile differences
| Benzodiazepine | GBL | |
|---|---|---|
| Class | Depressiva | Depressiva |
| Risk Level | moderate | high |
| Mechanisms | Positive allosterische Modulation am GABA-A-Rezeptor | Prodrug von GHB, GABA-B-Agonist |
| Receptors | GABA-A | GABA-B, GHB-Rezeptor |
| Effects | — | Anxiolyse (Angstlösung), Entspannung und Sedierung, Muskelrelaxation, Stressreduktion, Schlafförderung |
| Evidence | — | moderate |
GBL wird im Körper zu GHB metabolisiert, das als Agonist an GABA-Rezeptoren wirkt und sedierende sowie anxiolytische Effekte hervorruft.
Harm Reduction
No harm reduction data available
Evidence: not assessed · Sources: 2
Evidence: moderate · Sources: 6